Affymax, Takeda Report Positive Phase II Data On Anemia Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
Hematide maintained mean hemoglobin levels for up to 18 months in patients previously treated with epoetin alfa, the companies report.